Barington Companies Management LLC Makes New Investment in Kenvue Inc. $KVUE

Barington Companies Management LLC acquired a new position in shares of Kenvue Inc. (NYSE:KVUE) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 50,000 shares of the company’s stock, valued at approximately $812,000. Kenvue makes up about 0.6% of Barington Companies Management LLC’s investment portfolio, making the stock its 11th biggest holding.

A number of other large investors have also modified their holdings of the company. Salomon & Ludwin LLC bought a new position in Kenvue in the third quarter worth $25,000. NBT Bank N A NY increased its holdings in Kenvue by 180.3% in the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after buying an additional 1,006 shares during the period. Cornerstone Planning Group LLC increased its holdings in Kenvue by 705.2% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock valued at $25,000 after buying an additional 1,361 shares during the period. Golden State Wealth Management LLC raised its stake in shares of Kenvue by 150.1% in the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock valued at $32,000 after buying an additional 1,190 shares in the last quarter. Finally, Trust Co. of Vermont lifted its holdings in shares of Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Kenvue

In other Kenvue news, Director Jeffrey C. Smith purchased 3,200,000 shares of the business’s stock in a transaction that occurred on Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, with a total value of $55,584,000.00. Following the completion of the acquisition, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.68% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Barclays lifted their target price on shares of Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Friday. Canaccord Genuity Group raised their price target on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a report on Friday, January 9th. Zacks Research raised Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. Finally, Jefferies Financial Group downgraded Kenvue from a “buy” rating to a “hold” rating and cut their target price for the stock from $23.00 to $18.00 in a research report on Friday, January 30th. Three investment analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $19.58.

Kenvue Stock Up 0.9%

Shares of KVUE opened at $18.41 on Friday. The company has a market capitalization of $35.29 billion, a P/E ratio of 23.91, a PEG ratio of 4.21 and a beta of 0.51. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17. The business’s 50 day simple moving average is $17.85 and its 200-day simple moving average is $17.43. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $3.68 billion. During the same period last year, the firm posted $0.26 EPS. The business’s revenue was up 3.2% on a year-over-year basis. As a group, sell-side analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Stockholders of record on Wednesday, February 11th were paid a $0.2075 dividend. The ex-dividend date was Wednesday, February 11th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.5%. Kenvue’s dividend payout ratio (DPR) is 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.